Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Foslinanib Sodium (TRX818 Sodium) is an anticancer compound.It inhibits vasculogenic mimicry network formation in C8161 and SK-MEL-28 melanoma cells when used at concentrations ranging from less than or equal to 5 to 10 nM
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 202.00 | |
5 mg | In stock | $ 412.00 | |
10 mg | In stock | $ 613.00 | |
25 mg | In stock | $ 977.00 | |
50 mg | In stock | $ 1,320.00 | |
100 mg | In stock | $ 1,780.00 |
Description | Foslinanib Sodium (TRX818 Sodium) is an anticancer compound.It inhibits vasculogenic mimicry network formation in C8161 and SK-MEL-28 melanoma cells when used at concentrations ranging from less than or equal to 5 to 10 nM |
Synonyms | TRX818 Sodium |
Molecular Weight | 409.21 |
Formula | C16H11FNNa2O6P |
CAS No. | 1256037-62-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Foslinanib Sodium 1256037-62-3 Others TRX818 Sodium inhibitor inhibit